News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Press releases

2022

21 November, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
18 November, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
8 November, 2022
News
English
Regulatory
MAR
Report
Interim
Q3
IR
Optional
25 October, 2022
News
Corporate Information
Nomination Committee
English
Regulatory
Listing Regulation
IR
Optional
17 October, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
13 October, 2022
News
Corporate Information
Presentation
English
IR
Optional
6 October, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
30 August, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
23 August, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
19 August, 2022
News
English
Regulatory
MAR
VPML
Report
Interim
Q2
IR
Optional
18 August, 2022
News
Corporate Information
Nomination Committee
English
IR
Optional
10 August, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
mfn-cus-emcitate
13 July, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
mfn-cus-aladote
20 June, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
mfn-cus-emcitate
31 May, 2022
News
Corporate Action
Shares
English
Regulatory
LHFI
IR
Optional
30 May, 2022
News
Corporate Information
General meeting
Report of the AGM
English
Regulatory
Listing Regulation
IR
Optional
19 May, 2022
News
Corporate Action
Shares
Issuance
English
Regulatory
MAR
IR
Optional
6 May, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
5 May, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
28 April, 2022
News
Corporate Action
Prospectus
English
Regulatory
Listing Regulation
IR
Optional
26 April, 2022
News
English
Regulatory
MAR
Report
Interim
Q1
IR
Optional
20 April, 2022
News
English
Regulatory
VPML
Report
Annual
IR
Optional
13 April, 2022
News
Corporate Information
General meeting
Report of the AGM
English
Regulatory
Listing Regulation
IR
Optional
6 April, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
mfn-cus-emcitate
24 March, 2022
News
Corporate Information
Other Corporate Information
English
IR
Optional
mfn-cus-emcitate

Calendar and upcoming reports

December 1, 2022
Erik Penser Bank Temadag - Healthcare

December 15, 2022
DNB Nordic Healthcare Conference

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com